NEW YORK (GenomeWeb News) – Pressure BioSciences today reported that its second-quarter 2009 revenues more than doubled year over year, while the firm trimmed its net loss in half.

The South Easton, Mass.-based firm brought in revenues of $270,381 for the three-month period ended June 30, compared to $120,184 for the second quarter of 2008. Sales of its pressure cycling technology products and services rose 35 percent to $159,202 from $117,698.

The company cut its net loss in half to $814,049, or $.39 per share, from $$1.6 million, or $.72 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.